December 12, 2013

Ms. Valerie Amos
Under-Secretary-General for Humanitarian Affairs and Emergency Relief Coordinator
United Nations

Geneva, December 12, 2013

Dear Ms. Amos,

With this Open Letter, Doctors Without Borders/Médecins Sans Frontières (MSF) wishes to express its deep concern about the unacceptable performance of the United Nations humanitarian system in the Central African Republic over the last year.

November 16, 2013


My life with MSF started in the early nineties in Thailand. MSF was providing medical care in Burmese refugee camps along the Thai-Burmese border. Malaria was the main cause of morbidity and mortality among this population. It was resistant to most of the available drugs to the point that young children and pregnant woman had become untreatable. The MSF team was frustrated with this situation—they documented the resistances and looked for alternatives without finding a solution.

September 27, 2013

MSF calls on all state and non-state parties to the Syrian conflict to make immediate allowance for the delivery of humanitarian aid inside the country commensurate with the massive needs of the Syrian people.

July 15, 2013

As the next round of the Trans-Pacific Partnership Agreement (TPP) negotiations continues in Malaysia, MSF urges negotiating countries to reject provisions that threaten to restrict access to affordable medicines for millions of people.

June 27, 2013

Rohit Malpani, director of policy and advocacy at Doctors Without Borders/Médecins Sans Frontières (MSF)'s Access Campaign, provided witness testimony on June 27, 2013, during a U.S. Congressional hearing on India's trade policies.

June 05, 2013

Mego Terzian, President, MSF-France

June 05, 2013

After more than two years of raging conflict in Syria, humanitarian assistance inside the country and in neighboring states hosting Syrian refugees remains far below massive and growing needs.

November 21, 2012

MSF International President, Dr. Unni Karunakara, in his keynote speech at the 2012 Universities Allied for Essential Medicines conference:

August 21, 2012

An open letter to Joe Jiminez and Daniel Vassella, the CEO and President of Novartis, respectively. 

May 18, 2011

This letter was sent to Heads of State or Governments of Member States of the European Union, to Presidents of European Institutions, and to the offices of the UN High Commissioner for Refugees, the UN High Commissioner for Human Rights, and the International Organisation for Migration.